Prelude Therapeutics Incorporated (PRLD) total debt

Total debt · fiscal 2025
$17.79M

Prelude Therapeutics Incorporated (PRLD) carried total debt of $17.79M at the end of fiscal 2025 (December 31, 2025). That is 1.3% lower than the $18.03M of fiscal 2024. Figures as of 18 Nov 2026, 01:20 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Total debt, fiscal 2025
$17.79M
Change on fiscal 2024
−1.3%
Highest on record
$18.03Mfiscal 2024
Lowest on record
$1.83Mfiscal 2022
Fiscal years on record
42022–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Prelude Therapeutics Incorporated total debt, in more detail

Across the 4 fiscal years on record (2022–2025), the highest was $18.03M in fiscal 2024 and the lowest $1.83M in fiscal 2022.

Total debt was 0.3× shareholders' equity at the end of fiscal 2025.

History · 4 fiscal years

Total debt by fiscal year

Prelude Therapeutics Incorporated total debt, year by year

Prelude Therapeutics Incorporated (PRLD) total debt by fiscal year
Fiscal yearTotal debtChangeYear endedDebt ÷ equity
2025$17.79M 1.3% down0.3×
2024$18.03M 6.7% up0.1×
2023$16.89M 821.8% up0.1×
2022$1.83M—0.0×

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

How to read it

Debt magnifies results in both directions — set it against cash, equity and the profit available to pay the interest rather than reading it alone.

More on PRLD

Prelude Therapeutics Incorporated, figure by figure

Prelude Therapeutics Incorporated (PRLD) overview: price, valuation and scorecard

Prelude Therapeutics Incorporated total debt: questions and answers

How much debt does Prelude Therapeutics Incorporated have?

Prelude Therapeutics Incorporated (PRLD) carried total debt of $17.79M at the end of fiscal 2025 (December 31, 2025). That is 1.3% lower than the $18.03M of fiscal 2024.

What are the highest and lowest total debt figures on record for Prelude Therapeutics Incorporated?

Across the 4 fiscal years on record (2022–2025), the highest was $18.03M in fiscal 2024 and the lowest $1.83M in fiscal 2022.

How does Prelude Therapeutics Incorporated's debt compare with its equity?

Total debt was 0.3× shareholders' equity at the end of fiscal 2025.

How is Prelude Therapeutics Incorporated's total debt calculated?

Total debt adds the short-term and long-term borrowings on the balance sheet at the fiscal year-end; debt-to-equity divides it by shareholders' equity and is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Prelude Therapeutics Incorporated (PRLD) total debt”, data as of 18 November 2026. https://funkfolio.com/stock/PRLD/total-debt

Underlying data: the company's filings with the SEC and Yahoo Finance.